��������

Dennis Benjamin is a Scientific Advisor at Manifold Bio. Dennis has also served as Sr. VP, Research at Seattle Genetics from December 2004 to October 2019, Director, Biochemistry at Praecis Pharmaceuticals from September 1998 to December 2004, and Scientist at Genetics Institute from June 1987 to September 1990. Additionally, they have been a member of the scientific advisory board (SAB) at ZebiAI and Heceta BioSciences.

Dennis Benjamin has a Ph.D in medicinal chemistry from the University of California, San Francisco and did their undergraduate studies in chemistry at the Massachusetts Institute of Technology. Dennis then did a postdoctoral fellowship in protein chemistry at the University of Oxford.